Member Feedback

Original Date: November 12, 2020

The Precision Medicine Enablement via Advanced Diagnostics Workgroup and Pharmacogenomics Payment and Policy Taskforce leadership offers an overview of leveraging the power of pharmacogenomics (PGx) to improve patient care. Presenters demonstrate that the integration of PGx testing into CMM services can reduce costs, increase provider education and improve patient outcomes, satisfaction and access to care. The webinar reviews the cost-effectiveness of multi-gene PGx testing in a CMM practice and examine organizational case studies and a patient story that demonstrate PGx-testing benefits in a Medicare population.

Learning Objectives

1. Evaluate the impact of PGx as a tool used during the delivery of CMM services to achieve the quadruple aim.
2. Discover the key success factors associated with increased PGx testing as a tool during the CMM process, including education of patients and health care professionals, reimbursement of PGx testing and reduced clinic, ER visits and hospitalizations.
3. Discuss the cost-effectiveness of multigene pharmacogenomic testing during the CMM process in a Medicare population.
4. Identify how a patient’s health care journey is improved by the utilization of PGx testing along with CMM service delivery.

Speakers

Jill Bates, Pharm.D., MS, BCOP, FASHP
PHASeR Pharmacy Program Manager
Durham VA Health Care System

Brian Litten, JD
Chief Strategic Growth Officer
Tabula Rasa HealthCare

Original Date: November 13, 2020

The Health IT to Support Optimized Medication Use Workgroup leadership offers an overview of turning data into actionable information. Hear more about the four foundational pillars of health IT in order to provide leadership, guidance and recommendations that will enable broad practice adoption of a systematic approach to CMM use throughout the continuum of care. Through helpful tips, recommendations and actionable examples, learn how your company relates to organizations and partnerships of various sizes, levels of maturity and settings.

Learning Objectives: 

1. Discuss the capabilities and functionalities needed to leverage health IT at the point of care to efficiently and effectively optimize medications.
2. Uncover actionable data opportunities to get you started—regardless of your practice settings—to move your organization across key levels of maturity.
3. Understand helpful tips and recommendations of health IT to capture key data, population risk stratification, care coordination and outcome reporting.
4. Evaluate the tools you may have available to conduct a risk stratification process to identify those at risk of not meeting clinical goals of therapy as a first step in building the business case for more robust investment in CMM program design and support.

Speaker

Molly J. Ekstrand, BPharm, BCACP, AE-C
Account Medical Advisor
Boehringer Ingelheim

Original Date: November 17, 2020

The Payment and Policy Solutions Workgroup leadership discusses the value and necessity of key players to facilitate buy-in of CMM as well as policy solutions and payment reform options for both advocates and policy makers. In addition, learn how telehealth provides a path to collaborative, interprofessional care teams by examining the current state and identifying solutions to key barriers to support expansion of CMM.

Learning Objectives: 

1. Identify key stakeholder values to facilitate engagement and buy-in towards the adoption of CMM.
2. Discuss a CMM value framework, with policy solutions and payment reform options for programs, designed to save lives and save money through a patient-centered, team-based approach.
3. Learn how telehealth provides a path to interprofessional care teams working collaboratively to optimize medication use.
4. Analyze the key barriers for telehealth delivery of CMM implementation and evaluate the solutions to support expansion of CMM.

Speakers

Mary Ann Kliethermes, B.S. Pharm., Pharm.D., FAPhA, FCIOM
Director, Medication Safety and Quality
American Society of Health-System Pharmacists

Bayli Larson, Pharm.D., MS, BCPS
Executive Fellow, Association Leadership and Management
American Society of Health-System Pharmacists

Original Date: November 19, 2020

The Practice and Care Delivery Transformation Workgroup leadership discusses the various regions of practice transformation that are necessary to advance an integrated comprehensive medication management (CMM) practice. Peer-reviewed research is presented to identify the current state of evidence, how to overcome gaps in CMM implementation and the different metrics used to evaluate a CMM program. Presenters discuss examples of best practices in both the public and the private sector as well as effective, compelling strategies to encourage implementation and adoption.

Learning Objectives:

1. Determine the tools needed to address the current gaps in CMM implementation and research needed to work with health plans, employers and consumers.
2. Identify the classification and utilization of metrics in a CMM practice setting.
3. Showcase expert practices who have implemented successful CMM programs that optimize medication use through patient-centered, team-based services.
4. Examine the difference CMM makes for a patient by decreasing waste, increasing quality and saving both lives and money.

Speakers

Marcia Buck, Pharm.D., FCCP, BCPPS
Director of Clinical Practice Advancement
American College of Clinical Pharmacy

M. Shawn McFarland, Pharm.D., FCCP, BCACP
National Clinical Pharmacy Practice Program Manager, Clinical Practice Integration and Model Advancement, Clinical Pharmacy Practice Office, Pharmacy Benefits Management Services
Veterans Health Administration

Julie Groppi, Pharm.D., FASHP
National Program Manager, Clinical Pharmacy Practice, Policy and Standards, Clinical Pharmacy Practice Office (CPPO), Pharmacy Benefits Management (PBM) Service (10P4P)
VA Central Office

Heather Ourth, Pharm.D., BCPS, BCGP
National Program Manager: Clinical Pharmacy Practice Program and Outcomes Assessment, Pharmacy Benefits Management Services 10P4P
Department of Veterans Affairs

Curtis Haas, Pharm.D., FCCP
Chief Pharmacy Officer
University of Rochester Medical Center

Amie Brooks, Pharm.D., FCCP, BCACP
Director of Strategic Initiatives
American College of Clinical Pharmacy